Scottsdale TMS Therapy has expanded its interventional psychiatry services by introducing Spravato (esketamine) nasal spray treatments for adults with treatment-resistant depression. The clinic, located in Old Town Scottsdale, now offers this fast-acting antidepressant option alongside its existing transcranial magnetic stimulation (TMS) protocols and psychiatric medication management.
Conventional antidepressants typically require four to six weeks to produce measurable effects, a timeline that can be burdensome for patients with severe mood disorders. Esketamine, which acts on NMDA receptors to promote neuroplasticity, can reduce depressive symptoms within days, providing a more immediate therapeutic option. According to a spokesperson for Scottsdale TMS Therapy, 'When standard medications fail to deliver remission, it is an indication that the underlying neural networks require a different mechanism of stimulation. Spravato represents a major milestone in complex mood disorder care.'
The clinic operates as a fully REMS-certified facility, ensuring compliance with federal safety and monitoring standards. Each outpatient session includes pre-treatment health screenings, supervised self-administration, and a mandatory two-hour post-treatment observation period with continuous monitoring of blood pressure and vital signs. The treatment is provided in a comfort-focused setting featuring Apollo TMS chairs, private treatment rooms, an on-site cafe, and an outdoor patio.
Scottsdale TMS Therapy works with major commercial insurers and manages the full authorization process to support broad access to this interventional care. The clinic's board-certified psychiatrists and master's-level clinicians oversee all treatments, offering individualized care for major depressive disorder, anxiety, and OCD.
For more information about esketamine therapy and other services, visit Scottsdale TMS Therapy.
